electroCore, Inc , a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies.
infoelectroCore is a micro cap stock with a total market cap of 28.73M.
infoThey trade on the NASDAQ and had their IPO 5 years and 2 months ago.
infoelectroCore currently employs 62 people.
infoAs of Wednesday, Aug 23 2023, electroCore’s share price is $4.8.
News Relating to electroCore
Seeking Alpha
electroCore, Inc. (ECOR) Q2 2023 Earnings Call Transcript
Wednesday Aug 09 2023 at 22:14
electroCore, Inc. (NASDAQ:ECOR ) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Participants Daniel Goldberger – CEO & Director Brian Posner – CFO & Corporate Secretary Conference Call Participants John Vandermosten – Zacks Swayampakula Ramakanth – H.C. Wainwright & Co. Nick Sherwood – Maxim Tyler Bussian – Brookline Capital Markets Operator Greetings, and welcome to the electroCore Second Quarter 2023 Earnings Conference Call.
Seeking Alpha
electroCore, Inc. (ECOR) Q1 2023 Earnings Call Transcript
Wednesday May 03 2023 at 23:41
electroCore, Inc. (NASDAQ:ECOR ) Q1 2023 Earnings Conference Call May 3, 2023 4:30 PM ET Company Participants Nicole Jones – IR Dan Goldberger – Chief Executive Officer Brian Posner – Chief Financial Officer Conference Call Participants John Vandermosten – Zacks Small-Cap Research Ramakanth Swayampakula – H.C. Wainwright Kemp Dolliver – Brookline Capital Markets Nick Sherwood – Maxim Group Operator And welcome to the electroCore First Quarter 2023 Earnings Call.
GlobeNewsWire
electroCore to Participate at Annual Aegis Virtual Conference
Monday May 01 2023 at 16:01
ROCKAWAY, N.J., May 01, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (the “Company”), (NASDAQ: ECOR) a commercial-stage bioelectronic medicine and wellness company, today announced that electroCore’s Chief Executive Officer, Dan Goldberger, will present at the Annual Aegis Virtual Conference being held May 2-4, 2023.
InvestorPlace
7 Stocks to Sell as Borrowing Costs Rise
Tuesday Feb 28 2023 at 14:46
With major economic weakness possibly lurking around the corner, investors should consider targeting stocks to sell. Specifically, market participants should note securities that feature rising short borrow fees.
PennyStocks
5 Penny Stocks To Buy According To Analysts, Targets Up To 1,050%
Thursday Nov 17 2022 at 12:02
Analysts say these are penny stocks to buy but do you agree? The post 5 Penny Stocks To Buy According To Analysts, Targets Up To 1,050% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Seeking Alpha
electroCore, Inc. (ECOR) Q3 2022 Earnings Call Transcript
Sunday Nov 06 2022 at 11:25
electroCore, Inc. (NASDAQ:ECOR ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Nicole Jones – Investor Relations Dan Goldberger – Chief Executive Officer Brian Posner – Chief Financial Officer Peter Staats – Chief Medical Officer Conference Call Participants Destiny Hance – Ladenburg Thalmann John Vandermosten – Zacks Operator Greetings and welcome to the electroCore Third Quarter 2022 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
Seeking Alpha
electroCore, Inc. (ECOR) CEO Dan Goldberger on Q2 2022 Results – Earnings Call Transcript
Sunday Aug 07 2022 at 08:01
electroCore, Inc. (NASDAQ:ECOR ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Rich Cockrell – Investor Relations Dan Goldberger – Chief Executive Officer Brian Posner – Chief Financial Officer Conference Call Participants John Vandermosten – Zacks Operator Good afternoon, ladies and gentlemen and thank you for standing by. Welcome to the electroCore Second Quarter 2022 Earnings Call.
GlobeNewsWire
electroCore to Announce Second Quarter 2022 Financial Results on August 4
Thursday Jul 28 2022 at 08:00
ROCKAWAY, N.J., July 28, 2022 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that it will report financial results for the second quarter ended June 30, 2022, after the close of the market on Thursday, August 4, 2022. Management will host a conference call and webcast at 4:30 PM EDT to discuss the financial results and answer questions.
GlobeNewsWire
electroCore to Participate at Upcoming Investor Conferences
Wednesday May 18 2022 at 08:00
ROCKAWAY, N.J., May 18, 2022 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that electroCore’s Chief Executive Officer, Dan Goldberger, will be presenting at the H.C. Wainwright Global Investment Conference and LD Micro Invitational Conference.
Seeking Alpha
electroCore, Inc. (ECOR) CEO Dan Goldberger on Q1 2022 Results – Earnings Call Transcript
Sunday May 08 2022 at 22:36
electroCore, Inc. (NASDAQ:ECOR ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Rich Cockrell – Investor Relations Dan Goldberger – Chief Executive Officer Brian Posner – Chief Financial Officer Peter Staats – Chief Medical Officer Conference Call Participants Swayampakula Ramakanth – H.C. Wainwright Jeffrey Cohen – Ladenburg Thalmann John Vandermosten – Zacks Jeremy Pearlman – Maxim Group Operator Greetings and welcome to electroCore First Quarter 2022 Earnings Conference Call.
GlobeNewsWire
electroCore to Present at 2022 Maxim Virtual Growth Conference
Tuesday Mar 22 2022 at 08:00
ROCKAWAY, N.J., March 22, 2022 (GLOBE NEWSWIRE) — electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that electroCore’s Chief Executive Officer, Dan Goldberger, will be presenting at the 2022 Maxim Virtual Growth Conference.
Seeking Alpha
electroCore, Inc. (ECOR) CEO Daniel Goldberger on Q4 2021 Results – Earnings Call Transcript
Thursday Mar 10 2022 at 22:34
electroCore, Inc. (ECOR) CEO Daniel Goldberger on Q4 2021 Results – Earnings Call Transcript
GlobeNewsWire
electroCore to Present at 34th Annual Roth Conference
Monday Mar 07 2022 at 16:01
ROCKAWAY, N.J., March 07, 2022 (GLOBE NEWSWIRE) — electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will be presenting at the 34th Annual Roth Conference. Details for access to the presentation are as follows:
InvestorPlace
ECOR Stock Alert: Why Is electroCore Soaring Today?
Wednesday Jan 12 2022 at 17:27
electroCore skyrocketed today after the FDA gave its PTSD treatment a breakthrough designation. ECOR stock closed up 60% on the news!
PennyStocks
3 Top Penny Stocks to Add to Your Watchlist in Mid-January
Wednesday Jan 12 2022 at 13:37
Which penny stocks are you watching right now? The post 3 Top Penny Stocks to Add to Your Watchlist in Mid-January appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Benzinga
ElectroCore’s Vagus Nerve Stimulator Wins Breakthrough Device Tag For Stress Disorder
Wednesday Jan 12 2022 at 10:55
The FDA has granted Breakthrough Designation to ElectroCore Inc’s (NASDAQ:ECOR) gammaCore nVNS device for posttraumatic stress disorder (PTSD). The device showed a reduction of symptoms of PTSD by 31% when compared to sham.
Seeking Alpha
electroCore: Pioneering Bioelectronic Medicine
Thursday Jan 06 2022 at 12:44
electroCore is a developer and marketer of non-invasive vagus nerve stimulation devices for the treatment of pain. The Company’s gammaCore nVNS device is approved for cluster headache, and recently received label expansion for PH and HC in adults.
InvestorPlace
5 Stocks Insiders Are Still Buying (Even As Others Cash Out)
Friday Nov 12 2021 at 16:44
Insider sales are generally a sign the market is about to drop, but not everyone’s selling. Here are five companies with insider buying.
Seeking Alpha
electroCore, Inc. (ECOR) CEO Daniel Goldberger on Q3 2021 Results – Earnings Call Transcript
Sunday Nov 07 2021 at 00:58
electroCore, Inc. (ECOR) CEO Daniel Goldberger on Q3 2021 Results – Earnings Call Transcript
GlobeNewsWire
electroCore to Announce Third Quarter 2021 Financial Results on Thursday, November 4th
Thursday Oct 21 2021 at 08:00
ROCKAWAY, NJ, Oct. 21, 2021 (GLOBE NEWSWIRE) — electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report financial results for the third quarter ended September 30, 2021 after the close of the market on Thursday, November 4, 2021. Management will host a conference call and webcast at 4:30pm Eastern Time to discuss the financial results and answer questions.
GlobeNewsWire
electroCore Announces Regulatory Approval in Canada to Treat Adolescent Migraine
Thursday Oct 14 2021 at 08:00
Health Canada expands gammaCore label to include the acute and preventive treatment of migraine in adolescents Health Canada expands gammaCore label to include the acute and preventive treatment of migraine in adolescents
GlobeNewsWire
electroCore Presentation at the Cantor Fitzgerald Virtual Global Healthcare Conference
Thursday Sep 30 2021 at 09:05
ROCKAWAY, NJ, Sept. 30, 2021 (GLOBE NEWSWIRE) — electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its presentation at the Cantor Fitzgerald Virtual Global Healthcare Conference has been rescheduled to today, September 30, 2021 at 12:40 PM eastern time.
InvestorPlace
7 Best Penny Stocks to Buy on the Nasdaq for October
Wednesday Sep 29 2021 at 10:20
Penny stocks have a place in every portfolio when adjusted for risk. These 7 have the added safety of a Nasdaq listing.
GlobeNewsWire
electroCore Announces Open Access and Submission of Manuscript from SAVIOR-1 study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 Patients
Wednesday Sep 29 2021 at 08:00
ROCKAWAY, NJ, Sept. 29, 2021 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the original author manuscript from the SAVIOR-1 study; a prospective, randomized, controlled study evaluating non-invasive vagus nerve stimulation (nVNS) using gammaCore SapphireTM in patients admitted to the hospital for treatment of COVID-19; is available on MedRxiv and has been submitted for peer review. This study was an investigator-initiated trial conducted at the Hospital Clínico Universitario de Valencia, Spain.
GlobeNewsWire
electroCore to Participate at Upcoming Investor Conferences
Thursday Sep 23 2021 at 08:00
ROCKAWAY, NJ, Sept. 23, 2021 (GLOBE NEWSWIRE) — electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will give a corporate presentation at the Cantor Fitzgerald Virtual Global Healthcare Conference.
GlobeNewsWire
electroCore Announces New Patent Expanding Claims Related to Delivery of Non-Invasive Vagus Nerve Stimulation Therapy Using Mobile Devices
Wednesday Sep 15 2021 at 08:00
ROCKAWAY, NJ, Sept. 15, 2021 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the United States Patent and Trademark Office has issued US Patent No. 11,097,102 to electroCore, relating to devices, systems and methods integrated with, or coupled to, smartphones that allow patients to self-treat medical conditions, such as migraine headache, by electrical non-invasive stimulation of nerves. The ‘102 patent is the 8th US patent issued to ECOR in the company’s mobile connectivity platform, with additional US and International matters pending.
GlobeNewsWire
electroCore Announces New Reseller Agreement with Red One Medical Devices, LLC.
Tuesday Aug 24 2021 at 08:00
ROCKAWAY, NJ, Aug. 24, 2021 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced a reseller agreement with Red One Medical Devices, LLC. (Red One). The partnership will further expand availability of electroCore’s gammaCore platform in the federal marketplace.
Seeking Alpha
electroCore, Inc. (ECOR) CEO Dan Goldberger on Q2 2021 Results – Earnings Call Transcript
Sunday Aug 08 2021 at 11:28
electroCore, Inc. (ECOR) CEO Dan Goldberger on Q2 2021 Results – Earnings Call Transcript
Pulse2
ECOR Stock Price Increases 25% Intraday: Why It Happened
Friday Aug 06 2021 at 13:42
The stock price of electroCore, Inc. (NASDAQ: ECOR) increased by over 25% during intraday trading. This is why it happened.
Benzinga
ElectroCore Analyst: Nerve Stimulation Market Opportunity Is Large
Tuesday Jul 27 2021 at 18:03
A combination of a large total addressable market, regulatory clearance, strong partnerships and effective product has Ladenburg Thalmann analysts bullish on electroCore, Inc. (NASDAQ:ECOR). The electroCore Analyst: Jeffrey Cohen initiated coverage on electroCore with a Buy rating and $3 price target.
electroCore Bankruptcy Risk
The Altman Z-score is a formula that measures a company’s financial health and bankruptcy risk. It assigns a numerical score based on various financial ratios. The Z-score is divided into different zones. If the Z-score is above 2.99, it indicates a lower bankruptcy risk, classifying the company as ‘safe’ or ‘non-distressed’. If the score falls below 1.81, it suggests a higher risk, indicating potential financial distress or bankruptcy. The range between 1.81 and 2.99 is called the ‘gray zone’ or zone of ambiguity.
Learn more at Investopediaopen_in_new
electroCore’s Altman Z-score is -17.15 which is in the distress zone. This indicates a higher risk of financial distress and potential bankruptcy for the company. It can serve as a warning sign of significant financial challenges, requiring careful consideration by potential investors.
Derived from SEC.GOV filing dataopen_in_new
electroCore Insider Trading
Insider trading is when individuals employed by a company buy or sell its securities following legal procedures and regulations. Company executives, directors, and employees may be permitted to buy or sell shares if they follow specific rules, such as filing a Form 4 with the SEC within two business days.
Learn more at Investopediaopen_in_new
Over the last 3 months, 1 insider has bought $0.00 of common stock in electroCore on the stock market with no insider selling.
Derived from SEC.GOV filing dataopen_in_new
Debt & Income Analysis
Income quality measures a company’s operating cash flow to net income ratio. It helps investors and analysts assess the sustainability of a company’s earnings. A high QIR indicates strong cash flows, while a low QIR may indicate non-operating activities driving net income.
Learn more at WallStreetPrepopen_in_new
electroCore’s Income Quality of 0.66 is in line with its Industry Group of 0.68 (-2.9% lower)
electroCore’s Income Quality of 0.66 is in line with its Major Industry Group of 0.71 (-7.0% lower)
electroCore’s Income Quality of 0.66 is lower than its Sector of 0.75 (-12.0% lower)
Derived from SEC.GOV filing dataopen_in_new
Current ratio measures a company’s ability to pay off short-term debt with its current assets (assets that a company expects to use up or convert to cash within a year). It represents the $ amount of current assets a company has for every $1 of short-term debt. A high current ratio above 1.0 indicates that a company can meet its short-term obligations, while a low current ratio below 1.0 suggests difficulty.
Learn more at Investopediaopen_in_new
electroCore’s Current Ratio of 1.73 is lower than its Industry Group of 3.36 (-48.5% lower)
electroCore’s Current Ratio of 1.73 is lower than its Major Industry Group of 3.13 (-44.7% lower)
electroCore’s Current Ratio of 1.73 is lower than its Sector of 2.6 (-33.5% lower)
Derived from SEC.GOV filing dataopen_in_new
Value Analysis
PE ratio (price-to-earnings), measures a company’s stock price relative to its earnings per share. It helps investors evaluate whether its stock is overvalued or undervalued. A higher PE ratio indicates that investors are willing to pay more for a company’s earnings, while a lower PE ratio (above zero) suggests the company could be undervalued.
Learn more at Investopediaopen_in_new
Cannot compare a negative PE Ratio (-1.31 & -1.02)
Cannot compare a negative PE Ratio (-1.31 & -0.58)
Cannot compare a negative PE Ratio (-1.31 & -0.4)
Derived from SEC.GOV filing dataopen_in_new
The PB ratio (price-to-book), measures a company’s stock price relative to its book value (net value of a company’s assets reported on its balance sheet, after subtracting debt) per share. It is used to evaluate a company’s valuation, with a lower PB ratio (above zero) indicating a lower valuation and a higher PB ratio suggesting overvaluation.
Learn more at Investopediaopen_in_new
electroCore’s PB Ratio of 4.07 is greater than its Industry Group of 1.9 (114.2% greater)
electroCore’s PB Ratio of 4.07 is greater than its Major Industry Group of 1.93 (110.9% greater)
electroCore’s PB Ratio of 4.07 is greater than its Sector of 1.62 (151.2% greater)
Derived from SEC.GOV filing dataopen_in_new
Efficiency Analysis
ROE (Return on Equity), is a financial ratio that measures a company’s profitability relative to its shareholders’ equity (the amount of value in a company that belongs to the people who own shares). It indicates how efficiently a company generates profits per unit of equity invested. A high ROE suggests effective use of equity, while a low ROE indicates inefficiency.
Learn more at Investopediaopen_in_new
electroCore’s ROE of -3.1 is lower than its Industry Group of -0.26 (-1092.3% lower)
electroCore’s ROE of -3.1 is lower than its Major Industry Group of -0.09 (-3344.4% lower)
electroCore’s ROE of -3.1 is lower than its Sector of -0.03 (-10233.3% lower)
Derived from SEC.GOV filing dataopen_in_new
ROCE (Return on Capital Employed), is a financial ratio that measures a company’s profitability relative to the amount of capital invested in its operations. It indicates how well a company is generating profits from its capital investments. A high ROCE suggests effective use of capital, while a low ROCE indicates inefficiency.
Learn more at Investopediaopen_in_new
electroCore’s ROCE of -2.96 is lower than its Industry Group of -0.27 (-996.3% lower)
electroCore’s ROCE of -2.96 is lower than its Major Industry Group of -0.14 (-2014.3% lower)
electroCore’s ROCE of -2.96 is lower than its Sector of -0.04 (-7300.0% lower)
Derived from SEC.GOV filing dataopen_in_new